| Nia J Jenkins, MD | |
|
2211 Charlotte St, Kansas City, MO 64108-2733 | |
| (816) 404-4966 | |
| Not Available |
| Full Name | Nia J Jenkins |
|---|---|
| Gender | Female |
| Speciality | Obstetrics/gynecology |
| Experience | 10 Years |
| Location | 2211 Charlotte St, Kansas City, Missouri |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1760800940 | NPI | - | NPPES |
| Facility Name | Location | Facility Type |
|---|---|---|
| Truman Medical Center Hospital Hill | Kansas city, MO | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| University Health Physicians | 1153235825 | 301 |
News Archive
Accuri Cytometers, Inc., the fastest growing life sciences company marketing and producing revolutionary bench-top flow cytometer systems, and eBioscience, the number two supplier of research flow cytometry reagents, today announced that they have entered into a worldwide co-marketing agreement.
Sunesis Pharmaceuticals, Inc. today reported that it has completed enrollment in the REVEAL-1 (Response Evaluation of VorEloxin in AmL) trial, a Phase 2 dose regimen optimization trial of single agent voreloxin in newly diagnosed elderly acute myeloid leukemia (AML) patients who are unlikely to benefit from standard induction chemotherapy. A total of 113 patients were enrolled and dosed according to one of three dosing schedules.
Bronchopulmonary dysplasia is the most common illness that develops in babies born premature with underdeveloped lungs.
While carotid endarterectomy (CEA) is performed to prevent stroke, long-term survival is essential to ensure benefit, especially in asymptomatic patients. A new study presented at the 66th Vascular Annual Meeting presented by the Society for Vascular Surgery today examined patient factors associated with 5-year survival following CEA in patients with asymptomatic internal carotid artery (ICA) stenosis.
› Verified 5 days ago
| Entity Name | University Health Physicians |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1669456257 PECOS PAC ID: 1153235825 Enrollment ID: O20031117000701 |
News Archive
Accuri Cytometers, Inc., the fastest growing life sciences company marketing and producing revolutionary bench-top flow cytometer systems, and eBioscience, the number two supplier of research flow cytometry reagents, today announced that they have entered into a worldwide co-marketing agreement.
Sunesis Pharmaceuticals, Inc. today reported that it has completed enrollment in the REVEAL-1 (Response Evaluation of VorEloxin in AmL) trial, a Phase 2 dose regimen optimization trial of single agent voreloxin in newly diagnosed elderly acute myeloid leukemia (AML) patients who are unlikely to benefit from standard induction chemotherapy. A total of 113 patients were enrolled and dosed according to one of three dosing schedules.
Bronchopulmonary dysplasia is the most common illness that develops in babies born premature with underdeveloped lungs.
While carotid endarterectomy (CEA) is performed to prevent stroke, long-term survival is essential to ensure benefit, especially in asymptomatic patients. A new study presented at the 66th Vascular Annual Meeting presented by the Society for Vascular Surgery today examined patient factors associated with 5-year survival following CEA in patients with asymptomatic internal carotid artery (ICA) stenosis.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Nia J Jenkins, MD 2211 Charlotte St, Kansas City, MO 64108-2733 Ph: () - | Nia J Jenkins, MD 2211 Charlotte St, Kansas City, MO 64108-2733 Ph: (816) 404-4966 |
News Archive
Accuri Cytometers, Inc., the fastest growing life sciences company marketing and producing revolutionary bench-top flow cytometer systems, and eBioscience, the number two supplier of research flow cytometry reagents, today announced that they have entered into a worldwide co-marketing agreement.
Sunesis Pharmaceuticals, Inc. today reported that it has completed enrollment in the REVEAL-1 (Response Evaluation of VorEloxin in AmL) trial, a Phase 2 dose regimen optimization trial of single agent voreloxin in newly diagnosed elderly acute myeloid leukemia (AML) patients who are unlikely to benefit from standard induction chemotherapy. A total of 113 patients were enrolled and dosed according to one of three dosing schedules.
Bronchopulmonary dysplasia is the most common illness that develops in babies born premature with underdeveloped lungs.
While carotid endarterectomy (CEA) is performed to prevent stroke, long-term survival is essential to ensure benefit, especially in asymptomatic patients. A new study presented at the 66th Vascular Annual Meeting presented by the Society for Vascular Surgery today examined patient factors associated with 5-year survival following CEA in patients with asymptomatic internal carotid artery (ICA) stenosis.
› Verified 5 days ago
Susan Marie Mou, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 2101 Charlotte St, Kansas City, MO 64108 Phone: 816-404-7820 Fax: 816-404-8159 | |
Dr. Kristopher Shawn Lybarger, D.O. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 2340 E Meyer Blvd Bldg 2, Ste 546, Kansas City, MO 64132 Phone: 816-926-0777 Fax: 816-926-0707 | |
Ronald Edward Brunnabend Ii, D.O. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 2340 E Meyer Blvd Ste 598, Kansas City, MO 64132 Phone: 816-444-6888 | |
Douglas R Perryman, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 4400 Broadway Ste 302, Kansas City, MO 64111 Phone: 816-931-9344 Fax: 816-931-4168 | |
Anupama Kotha, MD Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 4401 Wornall Rd, Kansas City, MO 64111 Phone: 816-932-3584 Fax: 816-932-5873 | |
Zachary James Alholm, MD Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 2301 Holmes St, Kansas City, MO 64108 Phone: 816-404-0880 | |
Gerald Lee Miller Jr., MD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 6400 Prospect, #598, Kansas City, MO 64132 Phone: 816-444-6888 Fax: 816-444-1375 |